Business Description

Description
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform. It has a scalable business model integrating clinical resources in the United States and China.
Name Current Vs Industry Vs History
Cash-To-Debt 3.44
Equity-to-Asset -0.55
Debt-to-Equity -0.25
Debt-to-EBITDA N/A
N/A
N/A
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -15.76
Distress
Grey
Safe
Beneish M-Score 1.06
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate 17.3
3-Year EPS without NRI Growth Rate 18.4
3-Year FCF Growth Rate 28.9
Name Current Vs Industry Vs History
5-Day RSI 54.01
9-Day RSI 42.66
14-Day RSI 43.43
6-1 Month Momentum % 212
12-1 Month Momentum % 188.89

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.78
Quick Ratio 3.78
Cash Ratio 2.26

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -11.8
Shareholder Yield % -0.7

Profitability Rank

Name Current Vs Industry Vs History
FCF Margin % -2035.38

Financials (Next Earnings Date:2024-04-25 Est.)

BYSI's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:BYSI

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

BeyondSpring Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1.351
EPS (TTM) ($) 0
Beta 0.1
Volatility % 175.05
14-Day RSI 43.43
14-Day ATR ($) 0.290169
20-Day SMA ($) 2.615
12-1 Month Momentum % 188.89
52-Week Range ($) 0.6534 - 4
Shares Outstanding (Mil) 39.02

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

BeyondSpring Inc Filings

Filing Date Document Date Form
No Filing Data

BeyondSpring Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

BeyondSpring Inc Frequently Asked Questions

What is BeyondSpring Inc(BYSI)'s stock price today?
The current price of BYSI is $2.29. The 52 week high of BYSI is $4.00 and 52 week low is $0.65.
When is next earnings date of BeyondSpring Inc(BYSI)?
The next earnings date of BeyondSpring Inc(BYSI) is 2024-04-25 Est..
Does BeyondSpring Inc(BYSI) pay dividends? If so, how much?
BeyondSpring Inc(BYSI) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1